Erik D van Werkhoven

Learn More
INTRODUCTION Waiting to start treatment has been shown to be associated with tumor progression and upstaging in head and neck squamous cell carcinomas (HNSCCs). This diminishes the chance of cure and(More)
BACKGROUND This multicentre, randomised, open label, phase II/III study aimed to investigate the potential benefit of adding risedronate (R) to docetaxel (D) in patients with metastatic Castration(More)
BACKGROUND The European Association of Urology (EAU) guidelines advise an elective bilateral lymphadenectomy in clinically node-negative (cN0) patients with high-risk penile carcinoma (≥pT2, G3, or(More)
3565 Background: This study aimed to improve disease-free survival (DFS) for patients after radical resection of CRC liver metastases by adding bevacizumab to post resection chemotherapy with CAPOX.(More)
Background Hand-foot syndrome (HFS) is a common side-effect of capecitabine. S-1 is an oral fluoropyrimidine with comparable efficacy to capecitabine in gastrointestinal cancers but associated with a(More)